Similar articles

• "Under the radar": nurse practitioner prescribers and pharmaceutical industry promotions.

  Ladd EC, Mahoney DF, Emani S. Ladd EC, et al. Am J Manag Care. 2010 Dec 1;16(12):e358-62. Am J Manag Care. 2010. PMID: 21291293
• Physician attitudes toward industry: room for improvement.

  Marron J. Marron J. Arch Surg. 2010 Dec;145(12):1213. doi: 10.1001/archsurg.2010.258. Arch Surg. 2010. PMID: 21173299 No abstract available.
• The medical profession and the pharmaceutical industry: when will we open our eyes?

  Breen KJ. Breen KJ. Med J Aust. 2004 Apr 19;180(8):409-10. Med J Aust. 2004. PMID: 15089732
• The high cost of free lunch.

  Wall LL, Brown D. Wall LL, et al. Obstet Gynecol. 2007 Jul;110(1):169-73. doi: 10.1097/01.AOG.0000268800.46677.14. Obstet Gynecol. 2007. PMID: 17601912 Review.
• Nurse practitioners and physician assistants in the intensive care unit: an evidence-based review.

  Kleinpell RM, Ely EW, Grabenkort R. Kleinpell RM, et al. Crit Care Med. 2008 Oct;36(10):2888-97. doi: 10.1097/CCM.0b013e318186ba8c. Crit Care Med. 2008. PMID: 18766097 Review.